Samsung Biologics to enhance global ties at DCAT Week 2025

Samsung Biologics, the biotech arm of Samsung Group, said Monday that it will participate in DCAT Week 2025, taking place March 17-20 in New York, as part of its efforts to expand its global business network. Organized annually by the Drug, Chemical & Associated Technologies Association, the event has a history of over 130 years and is a premier networking platform for the global pharmaceutical and biotech industries. Samsung Biologics has participated in DCAT Week every year since 2016, exceptRead More